Abstract
Background
Endovascular revascularization (ER) and open revascularization (OR) are recognized treatment modalities for peripheral artery disease, but whether one technique provides better outcomes than the other is unclear, especially in patients with chronic or end-stage renal disease.
Methods
We conducted a systematic literature search on the PubMed, Scopus, and Google scholar databases. We considered randomized-controlled trials, and retrospective record-based and prospective studies for inclusion. All included studies compared patient outcomes between the two management modalities and reported adjusted effect sizes.
Results
We found the risks of in-hospital mortality (OR 0.52; 95% CI 0.30–0.92) and 30-day mortality (OR 0.63; 95% CI 0.49–0.80) during the post-operative period to be significantly lower in patients undergoing ER than in those undergoing OR. The pooled odds of amputation within 30 days of the post-operative period suggested a significantly higher risk of amputation in patients undergoing ER (OR 1.51; 95% CI 1.32–1.73) than in the others. Compared to patients undergoing OR, those undergoing ER had higher odds of being discharged to home (OR 2.30; 95% CI 1.58–3.36), lower odds of wound complications within 24 months of the post-operative period (OR 0.34; 95% CI 0.15–0.79), and a reduced length of hospital stay (WMD − 5.9; 95% CI − 10.8 to − 1.00).
Conclusions
For elderly patients with ESRD and chronic limb ischemia, ER may be the best choice due to its lower risk of mortality, lower odds of wound complications, reduced length of hospital stay, and reduced risk of re-intervention requirement when compared to OR. However, OR should be considered as an option when limb salvage is preferred.
Similar content being viewed by others
References
Hill NR, Fatoba ST, Oke JL et al (2016) Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS ONE 11:e0158765. https://doi.org/10.1371/journal.pone.0158765
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 382:339–352. https://doi.org/10.1016/S0140-6736(13)60595-4
Garimella PS, Hirsch AT (2014) Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes. Adv Chronic Kidney Dis 21:460–471. https://doi.org/10.1053/j.ackd.2014.07.005
Rajagopalan S, Dellegrottaglie S, Furniss AL et al (2006) Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114:1914–1922. https://doi.org/10.1161/CIRCULATIONAHA.105.607390
Dumaine RL, Montalescot G, Steg PG et al (2009) Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J 158:141-148.e1. https://doi.org/10.1016/j.ahj.2009.05.011
Nehler MR, Duval S, Diao L et al (2014) Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 60:686-695.e2. https://doi.org/10.1016/j.jvs.2014.03.290
Biancari F, Arvela E, Korhonen M et al (2012) End-stage renal disease and critical limb ischemia: a deadly combination? Scand J Surg 101:138–143. https://doi.org/10.1177/145749691210100211
Kodama A, Sugimoto M, Kuma S et al (2014) Clinical outcomes after infrainguinal bypass grafting for critical limb ischaemia in patients with dialysis-dependent end-stage renal failure. Eur J Vasc Endovasc Surg 48:695–702. https://doi.org/10.1016/j.ejvs.2014.08.022
Conte MS, Bradbury AW, Kolh P et al (2019) Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 69:3S-125S-e40. https://doi.org/10.1016/j.jvs.2019.02.016
Norgren L, Hiatt WR, Dormandy JA et al (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl S):S5-67. https://doi.org/10.1016/j.jvs.2006.12.037
Kudo T, Chandra FA, Kwun W-H et al (2006) Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 44:304–313. https://doi.org/10.1016/j.jvs.2006.03.040
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Ottawa Hospital Research Institute, Ottawa. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Higgins J, Green S (2009) Cochrane handbook for systematic reviews of interventions. Wiley
Ramanan B, Jeon-Slaughter H, Chen X et al (2019) Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis. J Vasc Surg 70:1217–1224. https://doi.org/10.1016/j.jvs.2018.12.054
Yuo TH, Wallace JR, Fish L et al (2019) Editor’s choice—comparison of outcomes after open surgical and endovascular lower extremity revascularisation among end stage renal disease patients on dialysis. Eur J Vasc Endovasc Surg 57:248–257. https://doi.org/10.1016/j.ejvs.2018.09.008
Meyer A, Schilling A, Kott M et al (2018) Open versus endovascular revascularization of below-knee arteries in patients with end-stage renal disease and critical limb ischemia. Vasc Endovasc Surg 52:613–620. https://doi.org/10.1177/1538574418789036
Fallon JM, Goodney PP, Stone DH et al (2015) Outcomes of lower extremity revascularization among the hemodialysis-dependent. J Vasc Surg 62:1183-1191.e1. https://doi.org/10.1016/j.jvs.2015.06.203
Stavroulakis K, Gkremoutis A, Borowski M et al (2020) Bypass grafting vs endovascular therapy in patients with non-dialysis-dependent chronic kidney disease and chronic limb-threatening ischemia (CRITISCH registry). J Endovasc Ther 27:599–607. https://doi.org/10.1177/1526602820938465
Casella IB, Sartori CH, Faustino CB et al (2020) Endovascular therapy provides similar results of bypass graft surgery in the treatment of infrainguinal multilevel arterial disease in patients with chronic limb-threatening ischemia in All GLASS stages. Ann Vasc Surg 68:400–408. https://doi.org/10.1016/j.avsg.2020.04.028
Meyer A, Lang W, Borowski M et al (2016) In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization. J Vasc Surg 63:966–973. https://doi.org/10.1016/j.jvs.2015.10.009
Shiraki T, Iida O, Takahara M et al (2017) Comparison of clinical outcomes after surgical and endovascular revascularization in hemodialysis patients with critical limb ischemia. J Atheroscler Thromb 24:621–629. https://doi.org/10.5551/jat.35915
Younes HK, Davies MG, Peden EK (2013) End-stage renal disease and limb salvage. Methodist Debakey Cardiovasc J 9:108–111. https://doi.org/10.14797/mdcj-9-2-108
Bradbury AW, Adam DJ, Bell J et al (2010) Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 51:52S-68S. https://doi.org/10.1016/j.jvs.2010.01.077
Yuksel A, Velioglu Y, Cayir MC et al (2018) Current status of arterial revascularization for the treatment of critical limb ischemia in infrainguinal atherosclerotic disease. Int J Angiol 27:132–137. https://doi.org/10.1055/s-0037-1620242
Dosluoglu HH, Lall P, Harris LM, Dryjski ML (2012) Long-term limb salvage and survival after endovascular and open revascularization for critical limb ischemia after adoption of endovascular-first approach by vascular surgeons. J Vasc Surg 56:361–371. https://doi.org/10.1016/j.jvs.2012.01.054
Mustapha JA, Katzen BT, Neville RF et al (2018) Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc 7:e009724. https://doi.org/10.1161/JAHA.118.009724
Aiello FA, Khan AA, Meltzer AJ et al (2012) Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg 55:371–379. https://doi.org/10.1016/j.jvs.2011.08.044 (discussion 380)
Parmar GM, Novak Z, Spangler E et al (2019) Statin use improves limb salvage after intervention for peripheral arterial disease. J Vasc Surg 70:539–546. https://doi.org/10.1016/j.jvs.2018.07.089
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare having no competing interests.
Ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sun, Y., Zhou, X. & Zhang, J. Bypass surgery versus endovascular intervention for lower extremity revascularization in patients with chronic renal disease or end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 54, 589–600 (2022). https://doi.org/10.1007/s11255-021-02940-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02940-5